Health imaging innovator Pro Medicus (ASX:PME) has bolstered its North American market presence, announcing two major five-year contract renewals with a combined minimum value of $40 million.
The agreements, facilitated through its US subsidiary Visage Imaging, involve long-term partners MedStar Health and Zwanger-Pesiri, highlighting the sustained demand for cloud-native diagnostic solutions in the global healthcare sector.
The larger of the two deals is a $31 million renewal with MedStar Health, the dominant health system in the Maryland and Washington, D.C. regions.
The agreement expands beyond the existing Visage 7 Viewer and Open Archive modules to include the new Visage 7 Cardiology module.
The transition reflects a broader trend of large-scale medical institutions consolidating their imaging needs onto a single, scalable enterprise platform.
In parallel, Pro Medicus secured a $9 million renewal with Long Island-based Zwanger-Pesiri, a prominent private outpatient radiology provider.
This marks the third contract term for the partnership, which has spanned over a decade.
CEO Dr Sam Hupert noted that both renewals were negotiated at an increased per-transaction fee, with significant potential upside as client volumes grow.
At the time of reporting, Pro Medicus' share price was $131.22.